Plasma miR-19b, miR-34a, and miR-146a expression in patients with type 2 diabetes mellitus and cataract: A pilot study. Biomol Biomed [Internet]. 2024 May 2 [cited 2024 May 9];:537–544. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/9933